Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.70
|
3.83
|
3.73
|
3.695
|
3.75
|
3.75
|
|
|
7 272.00
|
15.00
|
3.60
|
3.75
|
4.05
|
3.65
|
4.10
|
3.65
|
|
|
41 447.80
|
46.00
|
3.41
|
3.70
|
3.60
|
3.60
|
3.60
|
3.60
|
|
|
360.00
|
1.00
|
3.63
|
3.70
|
3.72
|
3.61
|
3.72
|
3.65
|
|
|
24 415.00
|
12.00
|
3.40
|
4.05
|
3.55
|
3.40
|
3.55
|
3.40
|
|
|
9 653.00
|
8.00
|
3.52
|
4.25
|
3.53
|
3.53
|
3.53
|
3.53
|
|
|
394.34
|
3.00
|
3.33
|
3.50
|
3.65
|
3.50
|
3.68
|
3.50
|
|
|
21 303.15
|
19.00
|
3.60
|
4.25
|
4.20
|
3.60
|
4.26
|
3.60
|
|
|
43 946.00
|
52.00
|
4.07
|
4.40
|
3.62
|
3.42
|
4.10
|
4.07
|
|
|
36 377.76
|
45.00
|
|
|
3.76
|
3.51
|
3.89
|
3.62
|
|
|
21 692.08
|
31.00
|
XORTX Therapeutics Inc (XORTX) is a drug development company primarily focused on orphan disease indications which have a uric acid imbalance as well as metabolic syndrome, diabetes and diabetic nephropathy